NEJM This Week — February 10, 2022
Featuring articles on molnupiravir for outpatient treatment of Covid-19, cemented or uncemented hemiarthroplasty for hip fracture, efficacy of the NVX-CoV2373 vaccine against Covid-19, PD-1 inhibition in relapsed cervical cancer, pembrolizumab for triple-negative breast cancer, and a pernicious cycle affecting premalignant stem cells; a review article on marginal-zone lymphomas; a case report of a man with bilateral hearing loss and eye redness; and Perspective articles on racial biology and medical misconceptions, on developing new models for health, and on roulette.
